(1)
A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. Journal of Pharmaceutical Negative Results 2022, 972-979. https://doi.org/10.47750/pnr.2022.13.S01.116.